Quantcast

Latest Access Pharmaceuticals Inc. Stories

2011-08-16 07:00:00

DALLAS and NEW YORK, Aug. 16, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, diabetes, and RNAi, has announced its second quarter 2011 investor conference call and the recent progress in its MuGard program. MuGard is a mucoadhesive oral wound rinse and coating that has been shown to be very effective in the management of oral mucositis, a...

2011-08-09 07:30:00

DALLAS and NEW YORK, Aug. 9, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that Community Specialty Pharmacy Network (CSPN), the 10th-largest network of specialty pharmacies in the U.S., has joined its specialty pharmacy network for MuGard, its lead product for oral mucositis. With more than 180 member...

2011-08-05 07:45:00

DALLAS and NEW YORK, Aug. 5, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, has hired Edelman, the leading full service global public relations firm, to support its media outreach initiatives. Edelman will assist Access in implementing a media communications outreach program primarily aimed at introducing MuGard...

2011-08-03 07:15:00

DALLAS and NEW YORK, Aug. 3, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, detailed the continued reimbursement progress for MuGard, highlighting the recent addition of third party payers Blue Cross Blue Shield of Hawaii, SummaCare and AvMed. MuGard is now being covered by these third party payer programs with...

2011-08-02 07:15:00

DALLAS and NEW YORK, Aug. 2, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that MuGard, its lead product for oral mucositis, has been added to Humana's pharmacy benefit network. Reimbursement coverage for MuGard is now available with standard pharmacy benefit copayment. Providing healthcare for over...

2011-07-28 07:15:00

DALLAS and NEW YORK, July 28, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, has launched its patient reimbursement and support center for its lead product for oral mucositis, MuGard. Referred to as a HUB, the MuGard Patient Reimbursement and Support Center (MuGard PRSC) operated by eMax Health provides a...

2011-07-21 07:15:00

DALLAS and NEW YORK, July 21, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that its lead product for oral mucositis, MuGard, is being covered by Harvard Pilgrim and has been added to its pharmaceutical drug benefit program. Covering over one million lives, Harvard Pilgrim is a premier insurance...

2011-07-19 07:30:00

DALLAS and NEW YORK, July 19, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that its lead product for oral mucositis, MuGard, is being covered by TRICARE, the U.S. military health plan for active duty service members and retirees of the seven uniformed services, their family members, survivors and others...

2011-07-14 07:30:00

DALLAS and NEW YORK, July 14, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that its lead product for oral mucositis, MuGard, has been added to CVS Caremark's pharmacy benefit network. Reimbursement coverage for MuGard is now available with standard pharmacy benefit copayment. Placement in the pharmacy...

2011-07-13 07:30:00

DALLAS and NEW YORK, July 13, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that it has signed an agreement to restructure the outstanding senior convertible promissory note scheduled to mature this year. The amended agreement provides for extension of 50% of the principal amount of the note until...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related